EDITORIAL/OP-ED

ROCHE AND FLEISHMAN-HILLARD

CEO BYLINED EDITORIAL REACHES CORPORATE AUDIENCE WITH PANDEMIC PREPAREDNESS MESSAGE

HOFMANN-LA ROCHE INC. (ROCHE) CEO GEORGE ABERCROMBIE SAYS THAT ONE THING KEEPS HIM UP AT NIGHT: THE FEAR THAT A DEADLY PANDEMIC FLU WILL HIT AND MILLIONS WILL NEED THE ROCHE-

PRODUCED ANTIVIRAL FLU MEDICATION TAMIFLU, BUT THE NEED WOULD BE IMPOSSIBLE TO MEET.